Key result
Review outlines essential periprocedural medications to optimize patient outcomes in interventional oncology.
Why the study?
Optimization of patient outcomes and experience in interventional oncology procedures requires consideration of pharmacologic agents used in the periprocedural period to avoid complications and manage side effects.
This review outlines the use of periprocedural medications such as antibiotics, narcotics, sedatives, and antiemetics to optimize patient outcomes and experience during interventional oncology procedures.
Answers are grounded in this paper and cite their sources.
May inform periprocedural medication selection in interventional oncology; leaves open standardization via prospective trials.
Significant advances in ablative and endovascular therapies have allowed interventional radiology to play a substantial role in the management of patients with malignant neoplasms. The evolution of these procedures and the optimization of patient outcomes and experience must take into account various elements of the periprocedural period. Some of the most important considerations within the periprocedural period are the pharmacologic agents used to avoid infectious complications, decrease pain, and manage side effects. In this article, we discuss some of the most commonly used medications in interventional oncology procedures including antibiotics, narcotics, sedatives, antiemetics, and others.
No takes yet. Share an insight, caveat, or question.
Boumezrag et al. (2022) conducted a review in Malignant neoplasms. Periprocedural medications (antibiotics, narcotics, sedatives, antiemetics) was evaluated. This review discusses the most commonly used periprocedural medications in interventional oncology, including antibiotics, narcotics, sedatives, and antiemetics, to optimize patient outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: